The biopharma industry operates under the constant drive to enhance productivity, reduce costs, and ensure product quality and consistency. To meet these demands, continuous biomanufacturing, process intensification and digitalisation have emerged as crucial solutions.

Meet our experts at this exciting event and follow a lively presentation by Fabian Stutz on the topic:

A machine-builider view on issues in cell and gene therapy manufacturing

  • Robots and automation: Possible applications in CGT manufacturing
  • Modularity as the key: Sally – case study from inoculum preparation to cryovial filling